Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GrowGeneration Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
7.98
14.4
29
79.7
193
422
278
226
189
162
Cost of revenue
5.78
11.1
22.6
57.7
142
304
208
165
145
118
Gross profit
2.2
3.27
6.44
22
51
118
70.3
61.3
43.7
43.3
Selling, general and administrative
9.28
20.9
39.5
36.8
29.8
29.2
26.3
Selling and marketing
0.11
0.26
0.27
0.74
1
4
4
1.8
2
1.6
General and administrative
0.39
1.02
1.6
3.17
5.01
Operating expenses
2.63
6.12
10.7
20.4
42.6
103
238
111
95.7
68.9
Operating income
-0.43
-2.85
-4.26
1.58
8.44
15
-168
-49.8
-52
-25.6
Interest expense
0.01
0.02
0.02
0.05
0.02
0.1
0.07
0
Interest income
0.08
0.15
0.04
0.49
0.58
2.7
2.7
1.73
Other non-operating income
-0.01
0.31
-0.82
-0.26
0.14
0.23
1.24
3.38
2.62
1.73
Pre-tax income
-0.43
1.32
8.58
15.2
-167
-46.5
-49.4
-23.9
Income tax
0
0
0
0
3.25
2.44
-2.89
0.03
0.16
0.19
Net income
-0.43
-2.54
-5.07
1.32
5.33
12.8
-164
-46.5
-49.5
-24
EBITDA
-0.37
-2.7
-3.9
2.63
10.9
27.6
-151
-33.2
-32.5
-14.3
EPS, basic
-0.04
-0.14
-0.18
0.04
0.12
0.22
-2.69
-0.76
-0.82
-0.40
EPS, diluted
-0.04
-0.14
-0.18
0.04
0.11
0.21
-2.69
-0.76
-0.82
-0.40
Shares, basic (weighted)
11.4
18.1
29.4
32.8
43.9
59.2
60.8
61.2
60.2
59.7
Shares, diluted (weighted)
11.4
18.1
29.4
33.9
46.5
60.5
60.8
61.2
60.2
59.7
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.61
1.22
14.6
13
178
41.4
40.1
29.8
27.5
30.4
Short-term investments
0
39.8
31.9
35.2
29
15.7
Receivables
0.39
0.65
0.86
2.95
3.9
5.74
8.34
8.9
7.36
10.7
Inventory
2.57
4.59
8.87
21.6
54
106
77.1
64.9
40.3
38.8
Other current assets
0.04
0.71
0.61
2.55
11.1
16.1
6.46
7.97
7.9
7.73
Total current assets
3.61
7.17
25
41.1
250
217
171
147
113
104
Property, plant and equipment
0.55
1.26
1.82
3.34
7.42
24.1
28.7
27.1
15.5
9.8
Lease right-of-use assets
7.63
12.1
43.7
46.4
39.9
34.5
27.1
Goodwill
0.24
0.59
8.75
17.8
63
125
16
7.53
1.61
2.08
Intangible assets
0.05
0.11
0.23
20.5
48.4
30.9
16.2
8.78
3.33
Other non-current assets
0.3
0.8
0.8
Total assets
4.44
9.25
35.9
70.9
355
459
293
239
174
147
Accounts payable
0.64
1.07
1.82
6.02
14.6
17
15.7
11.7
8.15
8.78
Accrued liabilities
0.67
2.04
1.54
2.53
2.36
3.27
Deferred revenue
2.5
5.16
11.7
4.34
5.36
2.4
4.02
Short-term debt
0.02
0.04
0.44
0.11
0.08
0.09
0.05
0
Total current liabilities
0.84
1.59
3.41
12.1
27.4
47.1
35.8
30.9
24.3
26
Long-term debt
0.04
0.08
0.38
0.24
0.16
0.07
0
Lease liabilities
5.81
9.48
38.5
40.7
34.4
29.6
23
Other non-current liabilities
0
0.59
0.32
0.35
0.54
Total liabilities
0.88
1.68
5.83
18.1
37.7
88
77
65.7
54.3
49.5
Total debt
0.07
0.12
0.81
0.35
0.24
0.16
0.05
0
Paid-in capital
4.7
11.3
38.8
60.7
320
361
370
373
376
377
Retained earnings
-1.15
-3.69
-8.77
-7.97
-2.64
10.1
-154
-200
-256
-280
Treasury stock
0
0
Shareholders' equity
3.56
7.58
29.5
52.8
317
371
216
173
120
97.5
Total equity
3.56
7.58
29.5
52.8
317
371
216
173
120
97.5
Total liabilities and equity
4.44
9.25
35.9
70.9
355
459
293
239
174
147
Shares outstanding
14.7
21.1
34.9
36.9
57.2
59.9
61
61.5
59.4
60.1
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0.43
-2.54
-5.07
1.32
5.33
12.8
-164
-46.5
-49.5
-24
Depreciation and amortization
0.05
0.15
0.35
1.05
2.44
12.6
17.1
16.6
19.4
11.3
Stock-based compensation
0.22
1.08
1.9
2.49
7.86
6.59
4.97
3.17
2.42
1.51
Deferred income tax
0
0.75
1.61
-2.36
0
0
Change in receivables
-0.4
-0.31
-0.24
-3.77
-3.84
-1.9
-3.11
-0.3
0.84
-3.2
Change in inventory
-1.26
-2.08
-0.79
-9.5
-19.2
-34.7
32.9
13.8
24.6
1.79
Change in payables
0.24
0.49
0.51
4.17
9.99
3.29
-3.36
-3.04
-3.71
1.51
Cash from operations
-1.42
-3.41
-1.54
-3.34
-0.21
5.16
11.9
1.42
-1.8
-9.45
Capital expenditures
-0.4
-0.06
Acquisitions
-80.8
-7.23
-3.05
0
-1.01
Purchases of investments
0
0
-75
-38.7
-98.7
-52.6
-35.7
Sales and maturities of investments
0
0
35.2
46.6
96.8
60.2
49.8
Cash from investing
-0.26
-1.18
-6.37
-11.8
-45.8
-139
-11.6
-11.4
5.73
12.6
Debt repaid
-0.03
-0.06
-0.45
-0.46
-0.11
-0.08
-0.11
-0.05
0
0
Stock issued
1.62
Share buybacks
0
0
-6.04
0
Cash from financing
1.59
5.19
21.3
13.5
211
-2.38
-1.69
-0.31
-6.21
-0.22
Net change in cash
-0.09
0.61
13.4
-1.66
165
-137
-1.32
-10.3
-2.29
2.94
Free cash flow
-3.81
-1.6
Interest paid
0.01
0.02
0.02
0.05
0.04
0.02
0.1
0.07
0
Income taxes paid
0
0
3.16
6.07
0
0.1
0.1
0.14
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.56 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
26.4%
Gross profit / revenue.
Operating margin
-10.8%
Operating income / revenue.
EBITDA margin
-5.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-10.0%
Pre-tax income / revenue.
Net margin
-10.1%
Net income / revenue.
Operating cash flow margin
-4.1%
Cash from operations / revenue.
Return on equity (ROE)
-18.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-12.3%
Net income / average total assets.
Return on invested capital (ROIC)
-21.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
15.8%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.7%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
4.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-14.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-16.5%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-3.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-1.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-14.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-3.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-18.8%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-23.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-21.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-15.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-20.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-16.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-0.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-0.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
5.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.89x
Current assets / current liabilities.
Quick ratio
2.20x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.60x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.28
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$2.79
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.11
Cash from operations / diluted weighted shares.
Book value per share
$1.51
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.55x
Market cap / revenue.
P/B
1.02x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.07x
Market cap / tangible book value, when positive.
EV/Sales
0.31x
Enterprise value / revenue.
Earnings yield
-18.3%
Net income / market cap (the inverse of P/E).
What was GrowGeneration Corp.'s revenue in fiscal 2025?
GrowGeneration Corp. reported revenue of $161.7M for fiscal 2025, 14.4% lower than the year before.
Was GrowGeneration Corp. profitable in fiscal 2025?
No. It reported a net loss of $24.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.